AI assistant
SCYNEXIS INC — Director's Dealing 2014
Jun 20, 2014
34648_dirs_2014-06-20_3c28ae83-ae95-4b19-8daa-b8d31279e068.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SCYNEXIS INC (SCYX)
CIK: 0001178253
Period of Report: 2014-06-18
Reporting Person: PRUETTE EILEEN (General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-18 | Stock Option (right to buy) | $9.64 | A | 9803 | Acquired | 2024-06-17 | Common Stock (9803) | Direct |
| 2014-06-18 | Stock Option (right to buy) | $24.48 | D | 9803 | Disposed | 2022-10-24 | Common Stock (9803) | Direct |
| 2014-06-18 | Stock Option (right to buy) | $9.64 | A | 25230 | Acquired | 2024-06-17 | Common Stock (25230) | Direct |
Footnotes
F1: The option vests and becomes exercisable with respect to 15% of the total number of underlying shares on August 20, 2013, with respect to 1.58% of the total number of underlying shares vest monthly over the 12-months period, and with respect to the remaining 2.75% of the underlying shares vest monthly over the 24-month period thereafter.
F2: In connection with the re-pricing of the option, the option was further amended to provide that the term of the option shall be extended until June 17, 2024. In connection with the amendments, the original option is deemed canceled and replaced with a new option.
F3: The option vests in 48 equal monthly installments from the grant date of June 18, 2014.